CervoMed
CRVO • NASDAQ
CervoMed is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John J. Alam, with a market cap of $34.4M.
CEOJohn J. Alam
Next Earnings
Upcoming earnings announcement for CervoMed
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.84
Revenue Estimate
$117.5K
Earnings History
Past 12 earnings reports for CervoMed
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.88Est: -$0.69 | -27.5% | $8.7MEst: $330.0K | +2544.3% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.84Est: -$0.61 | -37.7% | $322.6KEst: $1.1M | -71.7% | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.70Est: -$0.60 | -16.7% | $1.8MEst: $1.3M | +34.1% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.56Est: -$0.62 | +9.7% | $1.9MEst: $2.0M | -2.2% | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.80Est: -$0.58 | -37.9% | $2.2MEst: $1.9M | +12.6% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.55Est: -$0.41 | -34.1% | $1.9MEst: $3.1M | -36.8% | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.27Est: -$0.38 | +28.9% | $3.3MEst: $2.2M | +49.5% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.41Est: -$0.39 | -5.1% | $2.3MEst: $1.4M | +73.9% | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$1.55Est: -$0.62 | -150.0% | $2.5MEst: $1.0M | +149.1% | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.70 | — | $1.5M | — | — |
| Aug 8, 2023 | Q2 2023 | -$1.04 | — | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$1.95 | — | - | — | — |